These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 4333000)
1. Effects of chloroform, diethyl ether and a propiophenone derivative, 3-dimethylamino-2-methyl-2-phenoxypropiophenone hydrochloride, upon cyclic 3',5'-nucleotide phosphodiesterase. Ueda I; Okumura F Biochem Pharmacol; 1971 Aug; 20(8):1967-71. PubMed ID: 4333000 [No Abstract] [Full Text] [Related]
2. Inhibition of a cyclic nucleotide phosphodiesterase from beef heart by catecholamines and related compounds. Goren EN; Rosen OM Mol Pharmacol; 1972 May; 8(3):380-4. PubMed ID: 4339291 [No Abstract] [Full Text] [Related]
3. [Influence of cardio- and vasoactive substances on phosphodiesterase activity]. Pöch G; Juan H; Kukovetz WR Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):293-4. PubMed ID: 4310614 [No Abstract] [Full Text] [Related]
4. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by phenothiazine and reserpine derivatives. Honda F; Imamura H Biochim Biophys Acta; 1968 Jun; 161(1):267-9. PubMed ID: 4298921 [No Abstract] [Full Text] [Related]
6. Cyclic phosphodiesterase activity and the action of papaverine. Triner L; Vulliemoz Y; Schwartz I; Nahas GG Biochem Biophys Res Commun; 1970 Jul; 40(1):64-9. PubMed ID: 4318586 [No Abstract] [Full Text] [Related]
7. Cyclic AMP phosphodiesterase interaction with its inhibitor of the slime mold, Dictyostelium discoideum. Riedel V; Malchow D; Gerisch G; Nägele B Biochem Biophys Res Commun; 1972 Jan; 46(1):279-87. PubMed ID: 4331126 [No Abstract] [Full Text] [Related]
8. Purification and properties of 3',5'-cyclic nucleotide phosphodiesterase from dog heart. Nair KG Biochemistry; 1966 Jan; 5(1):150-7. PubMed ID: 4287216 [No Abstract] [Full Text] [Related]
9. [Influence of diuretics on 3',5'-AMP-phosphodiesterase]. Schultz G; Senft G Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):61-2. PubMed ID: 4297756 [No Abstract] [Full Text] [Related]
10. [Structural factors in inhibition of adenosine-3',5'monophosphate-cyclic-phosphodiesterase]. Lucacchini A; Montali U; Ranieri M; Rossi CA Boll Soc Ital Biol Sper; 1972 Jan; 48(1):17-9. PubMed ID: 4338014 [No Abstract] [Full Text] [Related]
11. New inhibitor of phosphodiesterase with anti-bronchoconstrictor properties. Davies GE; Rose FL; Somerville AR Nat New Biol; 1971 Nov; 234(45):50-1. PubMed ID: 4331553 [No Abstract] [Full Text] [Related]
12. Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis. Beavo JA; Rogers NL; Crofford OB; Baird CE; Hardman JG; Sutherland EW; Newman EV Ann N Y Acad Sci; 1971 Dec; 185():129-36. PubMed ID: 4330487 [No Abstract] [Full Text] [Related]
13. Cyclic 3',5'-nucleotide phosphodiesterase. Preparation of a partially inactive enzyme and its subsequent stimulation by snake venom. Cheung WY Biochim Biophys Acta; 1969 Nov; 191(2):303-15. PubMed ID: 4311147 [No Abstract] [Full Text] [Related]
14. The metabolism of adenosine 3',5'-cyclic phosphate. II. Some properties of adenosine-3',5'-cyclic-phosphate phosphodiesterase from the rat kidney. Dousa T; Rychlík I Biochim Biophys Acta; 1970 Mar; 204(1):10-7. PubMed ID: 4314465 [No Abstract] [Full Text] [Related]
15. Cyclic nucleotide phosphodiesterase and cyclic AMP. Thompson WJ; Appleman MM Ann N Y Acad Sci; 1971 Dec; 185():36-41. PubMed ID: 4330503 [No Abstract] [Full Text] [Related]
16. Biotransformation of diethyl ether and chloroform. Van Poznak A Int Anesthesiol Clin; 1974; 12(2):35-40. PubMed ID: 4211088 [No Abstract] [Full Text] [Related]
17. Cyclic nucleotide phosphodiesterase in Dictyostelium discoideum: interconversion of two enzyme forms. Chassy BM Science; 1972 Mar; 175(4025):1016-8. PubMed ID: 4333171 [TBL] [Abstract][Full Text] [Related]
18. Purification and properties of a phosphodiesterase from Avena leaf tissues. Udvardy J; Marrè E; Farkas GL Biochim Biophys Acta; 1970 Jun; 206(3):392-403. PubMed ID: 4394093 [No Abstract] [Full Text] [Related]
19. [Determination of the inhibitory activity of some substituted theophyllines on the phosphodiesterase specific for the adenosine 3'5'-monophosphate]. Lespagnol A; Debaert M; Mizon J; Mizon-Capron Therapie; 1970; 25(4):707-13. PubMed ID: 4318831 [No Abstract] [Full Text] [Related]
20. [On the mechanism of the cardiac effects of 2-bromo-LSD]. Pöch G; Kukovetz WR Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):244-5. PubMed ID: 4308587 [No Abstract] [Full Text] [Related] [Next] [New Search]